Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 127 of 127 entries
Sorted by: Best Match Show Resources per page
Disclosure of human immunodeficiency virus status to children in South Africa: A comprehensive analysis.

Southern African journal of HIV medicine

van Elsland SL, Peters RPH, Grobbelaar C, Ketelo P, Kok MO, Cotton MF, van Furth AM.
PMID: 31534786
South Afr J HIV Med. 2019 Aug 22;20(1):884. doi: 10.4102/sajhivmed.v20i1.884. eCollection 2019.

BACKGROUND: The extent of disclosure of HIV status to children and adolescents and the context facilitating their disclosure process have received little attention.OBJECTIVES: To assess disclosure and provide a comprehensive analysis of characteristics associated with disclosure to children (3-14...

Cite
van Elsland SL, Peters RPH, Grobbelaar C, et al. Disclosure of human immunodeficiency virus status to children in South Africa: A comprehensive analysis. South Afr J HIV Med. 2019;20(1):884doi: 10.4102/sajhivmed.v20i1.884.
van Elsland, S. L., Peters, R. P. H., Grobbelaar, C., Ketelo, P., Kok, M. O., Cotton, M. F., & van Furth, A. M. (2019). Disclosure of human immunodeficiency virus status to children in South Africa: A comprehensive analysis. Southern African journal of HIV medicine, 20(1), 884. https://doi.org/10.4102/sajhivmed.v20i1.884
van Elsland, Sabine L, et al. "Disclosure of human immunodeficiency virus status to children in South Africa: A comprehensive analysis." Southern African journal of HIV medicine vol. 20,1 (2019): 884. doi: https://doi.org/10.4102/sajhivmed.v20i1.884
van Elsland SL, Peters RPH, Grobbelaar C, Ketelo P, Kok MO, Cotton MF, van Furth AM. Disclosure of human immunodeficiency virus status to children in South Africa: A comprehensive analysis. South Afr J HIV Med. 2019 Aug 22;20(1):884. doi: 10.4102/sajhivmed.v20i1.884. eCollection 2019. PMID: 31534786; PMCID: PMC6739545.
Copy Download .nbib Format: NLM
Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria.

Diabetology & metabolic syndrome

Mbunkah HA, Meriki HD, Kukwah AT, Nfor O, Nkuo-Akenji T.
PMID: 25197324
Diabetol Metab Syndr. 2014 Aug 25;6(1):92. doi: 10.1186/1758-5996-6-92. eCollection 2014.

BACKGROUND: Several studies have reported that the metabolic syndrome (MS) is more common in subjects with HIV infection than in HIV-negative individuals. HIV infection and the use of Highly Active Antiretroviral Therapy (HAART) have been shown to predispose HIV-infected...

Cite
Mbunkah HA, Meriki HD, Kukwah AT, et al. Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria. Diabetol Metab Syndr. 2014;6(1):92doi: 10.1186/1758-5996-6-92.
Mbunkah, H. A., Meriki, H. D., Kukwah, A. T., Nfor, O., & Nkuo-Akenji, T. (2014). Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria. Diabetology & metabolic syndrome, 6(1), 92. https://doi.org/10.1186/1758-5996-6-92
Mbunkah, Herbert Afegenwi, et al. "Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria." Diabetology & metabolic syndrome vol. 6,1 (2014): 92. doi: https://doi.org/10.1186/1758-5996-6-92
Mbunkah HA, Meriki HD, Kukwah AT, Nfor O, Nkuo-Akenji T. Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria. Diabetol Metab Syndr. 2014 Aug 25;6(1):92. doi: 10.1186/1758-5996-6-92. eCollection 2014. PMID: 25197324; PMCID: PMC4155121.
Copy Download .nbib Format: NLM
Antiretroviral-induced adverse drug reactions in HIV-infected patients in Mali: a resource-limited setting experience.

International journal of basic and clinical pharmacology

Oumar AA, Dakouo M, Tchibozo A, Maiga M, Landouré G, Abdi-Bogoreh R, Tulkens PM, Dao S, Yombi JC.
PMID: 31879663
Int J Basic Clin Pharmacol. 2019 May;8(5):831-836. doi: 10.18203/2319-2003.ijbcp20191565.

BACKGROUND: There are few reports in the literature from sub-Saharan Africa (SSA) regarding antiretroviral-induced adverse drug reactions (ADRs). Antiretroviral therapy (ART) is now widely available in SSA, and ADRs during HIV infection are also frequent. In this study, we...

Cite
Oumar AA, Dakouo M, Tchibozo A, et al. Antiretroviral-induced adverse drug reactions in HIV-infected patients in Mali: a resource-limited setting experience. Int J Basic Clin Pharmacol. 2019;8(5):831-836doi: 10.18203/2319-2003.ijbcp20191565.
Oumar, A. A., Dakouo, M., Tchibozo, A., Maiga, M., Landouré, G., Abdi-Bogoreh, R., Tulkens, P. M., Dao, S., & Yombi, J. C. (2019). Antiretroviral-induced adverse drug reactions in HIV-infected patients in Mali: a resource-limited setting experience. International journal of basic and clinical pharmacology, 8(5), 831-836. https://doi.org/10.18203/2319-2003.ijbcp20191565
Oumar, Aboubacar Alassane, et al. "Antiretroviral-induced adverse drug reactions in HIV-infected patients in Mali: a resource-limited setting experience." International journal of basic and clinical pharmacology vol. 8,5 (2019): 831-836. doi: https://doi.org/10.18203/2319-2003.ijbcp20191565
Oumar AA, Dakouo M, Tchibozo A, Maiga M, Landouré G, Abdi-Bogoreh R, Tulkens PM, Dao S, Yombi JC. Antiretroviral-induced adverse drug reactions in HIV-infected patients in Mali: a resource-limited setting experience. Int J Basic Clin Pharmacol. 2019 May;8(5):831-836. doi: 10.18203/2319-2003.ijbcp20191565. PMID: 31879663; PMCID: PMC6931397.
Copy Download .nbib Format: NLM
A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021).

Medicinal research reviews

Li G, De Clercq E.
PMID: 34636044
Med Res Rev. 2021 Oct 12; doi: 10.1002/med.21858. Epub 2021 Oct 12.

John Charles Martin should be remembered as a visionary medicinal chemist who was involved in the coinvention, development, or management of many FDA-approved antiviral drugs such as ganciclovir, stavudine, didanosine, cidofovir, oseltamivir, adefovir dipivoxil, tenofovir disoproxil fumarate, tenofovir alafenamide,...

Cite
Li G, De Clercq E. A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021). Med Res Rev. 2021;doi: 10.1002/med.21858.
Li, G., & De Clercq, E. (2021). A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021). Medicinal research reviews, . https://doi.org/10.1002/med.21858
Li, Guangdi, and De Clercq, Erik. "A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021)." Medicinal research reviews vol. (2021). doi: https://doi.org/10.1002/med.21858
Li G, De Clercq E. A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021). Med Res Rev. 2021 Oct 12; doi: 10.1002/med.21858. Epub 2021 Oct 12. PMID: 34636044.
Copy Download .nbib Format: NLM
Haematological and biochemical response to treatment of HIV-1 infection with a combination of nevirapine + stavudine + lamivudine in Lagos Nigeria.

Turkish journal of haematology : official journal of Turkish Society of Haematology

Odunukwe N, Idıgbe O, Kanki P, Adewole T, Onwujekwe D, Audu R, Onyewuche J.
PMID: 27264834
Turk J Haematol. 2005 Sep 05;22(3):125-31.

To evaluate the effect of a combination of nevirapine + stavudine + lamivudine on Haematological and Biochemical values of HIV-1 positive patients in Lagos. Fifty patients who met the enrollment criteria for accelerated clinical trial were studied. Ten millimeters...

Cite
Odunukwe N, Idıgbe O, Kanki P, et al. Haematological and biochemical response to treatment of HIV-1 infection with a combination of nevirapine + stavudine + lamivudine in Lagos Nigeria. Turk J Haematol. 2005;22(3):125-31
Odunukwe, N., Idıgbe, O., Kanki, P., Adewole, T., Onwujekwe, D., Audu, R., & Onyewuche, J. (2005). Haematological and biochemical response to treatment of HIV-1 infection with a combination of nevirapine + stavudine + lamivudine in Lagos Nigeria. Turkish journal of haematology : official journal of Turkish Society of Haematology, 22(3), 125-31.
Odunukwe, Nkiru, et al. "Haematological and biochemical response to treatment of HIV-1 infection with a combination of nevirapine + stavudine + lamivudine in Lagos Nigeria." Turkish journal of haematology : official journal of Turkish Society of Haematology vol. 22,3 (2005): 125-31.
Odunukwe N, Idıgbe O, Kanki P, Adewole T, Onwujekwe D, Audu R, Onyewuche J. Haematological and biochemical response to treatment of HIV-1 infection with a combination of nevirapine + stavudine + lamivudine in Lagos Nigeria. Turk J Haematol. 2005 Sep 05;22(3):125-31. PMID: 27264834.
Copy Download .nbib Format: NLM
Children with HIV are not small adults: what is different in pharmacology?.

Current opinion in HIV and AIDS

Lʼhomme R, Warris A, Gibb D, Burger D.
PMID: 19372919
Curr Opin HIV AIDS. 2007 Sep;2(5):405-9. doi: 10.1097/COH.0b013e3282ced13f.

PURPOSE OF REVIEW: The pharmacokinetics of antiretroviral drugs are highly variable among HIV-infected children. This review describes pharmacokinetic processes in children and recent pharmacokinetic data in children with HIV. The general lack of pharmacokinetic data and the potential role...

Cite
Lʼhomme R, Warris A, Gibb D, et al. Children with HIV are not small adults: what is different in pharmacology?. Curr Opin HIV AIDS. 2007;2(5):405-9doi: 10.1097/COH.0b013e3282ced13f.
Lʼhomme, R., Warris, A., Gibb, D., & Burger, D. (2007). Children with HIV are not small adults: what is different in pharmacology?. Current opinion in HIV and AIDS, 2(5), 405-9. https://doi.org/10.1097/COH.0b013e3282ced13f
Lʼhomme, Rafaëlla, et al. "Children with HIV are not small adults: what is different in pharmacology?." Current opinion in HIV and AIDS vol. 2,5 (2007): 405-9. doi: https://doi.org/10.1097/COH.0b013e3282ced13f
Lʼhomme R, Warris A, Gibb D, Burger D. Children with HIV are not small adults: what is different in pharmacology?. Curr Opin HIV AIDS. 2007 Sep;2(5):405-9. doi: 10.1097/COH.0b013e3282ced13f. PMID: 19372919.
Copy Download .nbib Format: NLM
Management and therapy of chronic hepatitis C in HIV.

Current opinion in HIV and AIDS

Soriano V, Vispo E, Martin-Carbonero L, Labarga P, Garcia-Samaniego J, Barreiro P.
PMID: 19372931
Curr Opin HIV AIDS. 2007 Nov;2(6):482-8. doi: 10.1097/COH.0b013e3282f0fd8d.

PURPOSE OF REVIEW: Chronic hepatitis C is currently one of the leading causes of hospitalization and death in HIV+ persons. Treatment is particularly challenging in coinfected patients due to lower efficacy and more side effects.RECENT FINDINGS: The combination of...

Cite
Soriano V, Vispo E, Martin-Carbonero L, et al. Management and therapy of chronic hepatitis C in HIV. Curr Opin HIV AIDS. 2007;2(6):482-8doi: 10.1097/COH.0b013e3282f0fd8d.
Soriano, V., Vispo, E., Martin-Carbonero, L., Labarga, P., Garcia-Samaniego, J., & Barreiro, P. (2007). Management and therapy of chronic hepatitis C in HIV. Current opinion in HIV and AIDS, 2(6), 482-8. https://doi.org/10.1097/COH.0b013e3282f0fd8d
Soriano, Vincent, et al. "Management and therapy of chronic hepatitis C in HIV." Current opinion in HIV and AIDS vol. 2,6 (2007): 482-8. doi: https://doi.org/10.1097/COH.0b013e3282f0fd8d
Soriano V, Vispo E, Martin-Carbonero L, Labarga P, Garcia-Samaniego J, Barreiro P. Management and therapy of chronic hepatitis C in HIV. Curr Opin HIV AIDS. 2007 Nov;2(6):482-8. doi: 10.1097/COH.0b013e3282f0fd8d. PMID: 19372931.
Copy Download .nbib Format: NLM
Showing 121 to 127 of 127 entries